Cargando…

Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab

Detalles Bibliográficos
Autores principales: Lee, Min Young, Lee, Woo In, Kang, So Young, Kim, Myeong Hee, Park, Young Shil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Laboratory Medicine 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467840/
https://www.ncbi.nlm.nih.gov/pubmed/36045063
http://dx.doi.org/10.3343/alm.2023.43.1.96
_version_ 1784788280159502336
author Lee, Min Young
Lee, Woo In
Kang, So Young
Kim, Myeong Hee
Park, Young Shil
author_facet Lee, Min Young
Lee, Woo In
Kang, So Young
Kim, Myeong Hee
Park, Young Shil
author_sort Lee, Min Young
collection PubMed
description
format Online
Article
Text
id pubmed-9467840
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Society for Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-94678402022-12-26 Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab Lee, Min Young Lee, Woo In Kang, So Young Kim, Myeong Hee Park, Young Shil Ann Lab Med Letter to the Editor Korean Society for Laboratory Medicine 2023-01-01 2022-09-01 /pmc/articles/PMC9467840/ /pubmed/36045063 http://dx.doi.org/10.3343/alm.2023.43.1.96 Text en © Korean Society for Laboratory Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Lee, Min Young
Lee, Woo In
Kang, So Young
Kim, Myeong Hee
Park, Young Shil
Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
title Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
title_full Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
title_fullStr Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
title_full_unstemmed Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
title_short Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
title_sort verification and comparison of chromogenic factor viii activity assays in patients with hemophilia treated with and without emicizumab
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467840/
https://www.ncbi.nlm.nih.gov/pubmed/36045063
http://dx.doi.org/10.3343/alm.2023.43.1.96
work_keys_str_mv AT leeminyoung verificationandcomparisonofchromogenicfactorviiiactivityassaysinpatientswithhemophiliatreatedwithandwithoutemicizumab
AT leewooin verificationandcomparisonofchromogenicfactorviiiactivityassaysinpatientswithhemophiliatreatedwithandwithoutemicizumab
AT kangsoyoung verificationandcomparisonofchromogenicfactorviiiactivityassaysinpatientswithhemophiliatreatedwithandwithoutemicizumab
AT kimmyeonghee verificationandcomparisonofchromogenicfactorviiiactivityassaysinpatientswithhemophiliatreatedwithandwithoutemicizumab
AT parkyoungshil verificationandcomparisonofchromogenicfactorviiiactivityassaysinpatientswithhemophiliatreatedwithandwithoutemicizumab